cbdMD, Inc.
YCBD
$0.72
-$0.01-1.12%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -1.89% | 3.61% | -10.96% | 8.52% | -4.87% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.89% | 3.61% | -10.96% | 8.52% | -4.87% |
| Cost of Revenue | 17.67% | -7.56% | 0.30% | -0.32% | -5.78% |
| Gross Profit | -11.74% | 13.18% | -16.82% | 14.67% | -4.41% |
| SG&A Expenses | 3.09% | 2.74% | -2.31% | -10.61% | -24.64% |
| Depreciation & Amortization | -17.65% | -8.93% | -2.64% | -1.62% | 5.04% |
| Other Operating Expenses | -76.24% | 150.55% | 11.08% | -71.19% | -40.41% |
| Total Operating Expenses | 1.99% | 10.95% | -0.80% | -11.68% | -19.27% |
| Operating Income | -231.75% | -116.61% | -136.83% | 68.68% | 91.90% |
| Income Before Tax | -1,974.83% | -345.03% | -294.76% | 84.03% | 101.52% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1,974.83% | -345.03% | -294.76% | 84.03% | 101.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,974.83% | -345.03% | -294.76% | 84.03% | 101.52% |
| EBIT | -231.75% | -116.61% | -136.83% | 68.68% | 91.90% |
| EBITDA | -119.27% | -1,371.53% | -562.25% | 84.14% | 127.07% |
| EPS Basic | 97.92% | 93.71% | 82.35% | 82.44% | 67.90% |
| Normalized Basic EPS | 76.03% | 76.90% | 82.38% | 85.51% | 95.43% |
| EPS Diluted | 97.92% | 93.71% | 82.35% | 82.44% | 67.90% |
| Normalized Diluted EPS | 76.03% | 76.90% | 82.38% | 85.51% | 95.43% |
| Average Basic Shares Outstanding | 1,482.43% | 835.69% | 1,187.78% | 110.32% | 53.74% |
| Average Diluted Shares Outstanding | 1,482.43% | 835.69% | 1,187.78% | 110.32% | 53.74% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |